These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34061819)

  • 1. An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability.
    Hayford CE; Tyson DR; Robbins CJ; Frick PL; Quaranta V; Harris LA
    PLoS Biol; 2021 Jun; 19(6):e3000797. PubMed ID: 34061819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cells undergoing epigenetic transition show short-term resistance and are transformed into cells with medium-term resistance by drug treatment.
    Poojan S; Bae SH; Min JW; Lee EY; Song Y; Kim HY; Sim HW; Kang EK; Kim YH; Lee HO; Hong Y; Park WY; Jang H; Hong KM
    Exp Mol Med; 2020 Jul; 52(7):1102-1115. PubMed ID: 32661348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of non-genetic heterogeneity on cancer cell death.
    Inde Z; Dixon SJ
    Crit Rev Biochem Mol Biol; 2018 Feb; 53(1):99-114. PubMed ID: 29250983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition.
    Soucheray M; Capelletti M; Pulido I; Kuang Y; Paweletz CP; Becker JH; Kikuchi E; Xu C; Patel TB; Al-Shahrour F; Carretero J; Wong KK; Jänne PA; Shapiro GI; Shimamura T
    Cancer Res; 2015 Oct; 75(20):4372-83. PubMed ID: 26282169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
    Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
    J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
    Cho SY; Chae J; Na D; Kang W; Lee A; Min S; Kang J; Choi B; Lee J; Sung CO; Chuang JH; Lee C; Lee WS; Park H; Kim JI
    Clin Cancer Res; 2019 May; 25(9):2821-2834. PubMed ID: 30670495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
    Biswas A; De S
    Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance, epigenetics, and tumor cell heterogeneity.
    Hoey T
    Sci Transl Med; 2010 Apr; 2(28):28ps19. PubMed ID: 20410528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing is everything: stochastic origins of cell-to-cell variability in cancer cell death.
    Skommer J; Raychaudhuri S; Wlodkowic D
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):307-14. PubMed ID: 21196172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors.
    Balko JM; Potti A; Saunders C; Stromberg A; Haura EB; Black EP
    BMC Genomics; 2006 Nov; 7():289. PubMed ID: 17096850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations of KIT during clonal expansion and subsequent acquisition of resistance to toceranib in a canine mast cell tumor cell line.
    Kurita S; Miyamoto R; Tani H; Kobayashi M; Sasaki T; Tamura K; Bonkobara M
    J Vet Pharmacol Ther; 2019 Nov; 42(6):673-681. PubMed ID: 31553064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling of afatinib-resistant non-small cell lung cancer cells in vivo derived from mice.
    Chung CT; Yeh KC; Lee CH; Chen YY; Ho PJ; Chang KY; Chen CH; Lai YK; Chen CT
    Pharmacol Res; 2020 Nov; 161():105183. PubMed ID: 32896579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies.
    Wajapeyee N; Gupta R
    Cancer Res; 2021 Nov; 81(22):5589-5595. PubMed ID: 34531319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stochastic phenomena and the tumoral process].
    Capp JP
    Med Sci (Paris); 2014; 30(6-7):693-8. PubMed ID: 25014464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic gene expression noise and phenotypic diversification of clonal cell populations.
    Neildez-Nguyen TM; Parisot A; Vignal C; Rameau P; Stockholm D; Picot J; Allo V; Le Bec C; Laplace C; Paldi A
    Differentiation; 2008 Jan; 76(1):33-40. PubMed ID: 17825084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG hypermethylation contributes to decreased expression of PTEN during acquired resistance to gefitinib in human lung cancer cell lines.
    Maeda M; Murakami Y; Watari K; Kuwano M; Izumi H; Ono M
    Lung Cancer; 2015 Mar; 87(3):265-71. PubMed ID: 25638724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability.
    Derrien J; Guérin-Charbonnel C; Gaborit V; Campion L; Devic M; Douillard E; Roi N; Avet-Loiseau H; Decaux O; Facon T; Mallm JP; Eils R; Munshi NC; Moreau P; Herrmann C; Magrangeas F; Minvielle S
    Genome Med; 2021 Aug; 13(1):127. PubMed ID: 34372935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway.
    Wang L; Dong X; Ren Y; Luo J; Liu P; Su D; Yang X
    Cell Death Dis; 2018 Jan; 9(2):129. PubMed ID: 29374157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.